6 Adverse Reactions The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.3)] Hypersensitivity Reactions [see Warnings and Precautions (5.4)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.5)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.6)] Diabetic Retinopathy Complications in Patients with a History of Diabetic Retinopathy [see Warnings and Precautions (5.7)] Acute Gallbladder Disease [see Warnings and Precautions (5.8)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.9)] The most common adverse reactions, reported in 5% of patients treated with MOUNJARO are nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain

Early Benefit: By week 20, MACE rates had already diverged (HR 0.58, 95% CI 0.410.81), suggesting rapid onset of cardioprotective effects, well before maximal weight loss is achieved
Groop PH, Cooper ME, Perkovic V, et al
TRIUMPH-Outcomes estudia desenlaces cardiovasculares y renales mayores en una poblacin de alto riesgo
Temerdashev, Z.A., Frolova, N.A., and Kolychev, I.A., Determination of phenolic compounds in medicinal herbs by reversed-phase HPLC, J
Your brainstem A group of nerve cells deep in the brain also produce GLP-1